Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1882 1
1931 1
1934 1
1939 1
1945 2
1947 2
1948 1
1949 1
1950 1
1951 2
1952 1
1953 2
1954 4
1955 2
1956 4
1957 4
1958 4
1959 5
1960 6
1961 4
1962 11
1963 6
1964 7
1965 5
1966 7
1967 7
1968 13
1969 13
1970 13
1971 18
1972 20
1973 21
1974 17
1975 18
1976 34
1977 32
1978 29
1979 28
1980 37
1981 36
1982 32
1983 30
1984 51
1985 43
1986 44
1987 42
1988 46
1989 49
1990 53
1991 51
1992 72
1993 61
1994 81
1995 78
1996 93
1997 105
1998 108
1999 127
2000 144
2001 142
2002 160
2003 164
2004 189
2005 214
2006 244
2007 262
2008 291
2009 327
2010 372
2011 433
2012 432
2013 393
2014 447
2015 467
2016 493
2017 517
2018 502
2019 497
2020 567
2021 665
2022 641
2023 671
2024 583
2025 375

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,661 results

Results by year

Filters applied: . Clear all
Page 1
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.
Breast Cancer Association Consortium; Dorling L, Carvalho S, Allen J, González-Neira A, Luccarini C, Wahlström C, Pooley KA, Parsons MT, Fortuno C, Wang Q, Bolla MK, Dennis J, Keeman R, Alonso MR, Álvarez N, Herraez B, Fernandez V, Núñez-Torres R, Osorio A, Valcich J, Li M, Törngren T, Harrington PA, Baynes C, Conroy DM, Decker B, Fachal L, Mavaddat N, Ahearn T, Aittomäki K, Antonenkova NN, Arnold N, Arveux P, Ausems MGEM, Auvinen P, Becher H, Beckmann MW, Behrens S, Bermisheva M, Białkowska K, Blomqvist C, Bogdanova NV, Bogdanova-Markov N, Bojesen SE, Bonanni B, Børresen-Dale AL, Brauch H, Bremer M, Briceno I, Brüning T, Burwinkel B, Cameron DA, Camp NJ, Campbell A, Carracedo A, Castelao JE, Cessna MH, Chanock SJ, Christiansen H, Collée JM, Cordina-Duverger E, Cornelissen S, Czene K, Dörk T, Ekici AB, Engel C, Eriksson M, Fasching PA, Figueroa J, Flyger H, Försti A, Gabrielson M, Gago-Dominguez M, Georgoulias V, Gil F, Giles GG, Glendon G, Garcia EBG, Alnæs GIG, Guénel P, Hadjisavvas A, Haeberle L, Hahnen E, Hall P, Hamann U, Harkness EF, Hartikainen JM, Hartman M, He W, Heemskerk-Gerritsen BAM, Hillemanns P, Hogervorst FBL, Hollestelle A, Ho WK, Hooning MJ, Howell A, Humphreys K… See abstract for full author list ➔ Breast Cancer Association Consortium, et al. Among authors: schmidt mk. N Engl J Med. 2021 Feb 4;384(5):428-439. doi: 10.1056/NEJMoa1913948. Epub 2021 Jan 20. N Engl J Med. 2021. PMID: 33471991 Free PMC article.
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Geyer CE Jr, Garber JE, Gelber RD, Yothers G, Taboada M, Ross L, Rastogi P, Cui K, Arahmani A, Aktan G, Armstrong AC, Arnedos M, Balmaña J, Bergh J, Bliss J, Delaloge S, Domchek SM, Eisen A, Elsafy F, Fein LE, Fielding A, Ford JM, Friedman S, Gelmon KA, Gianni L, Gnant M, Hollingsworth SJ, Im SA, Jager A, Jóhannsson ÓÞ, Lakhani SR, Janni W, Linderholm B, Liu TW, Loman N, Korde L, Loibl S, Lucas PC, Marmé F, Martinez de Dueñas E, McConnell R, Phillips KA, Piccart M, Rossi G, Schmutzler R, Senkus E, Shao Z, Sharma P, Singer CF, Španić T, Stickeler E, Toi M, Traina TA, Viale G, Zoppoli G, Park YH, Yerushalmi R, Yang H, Pang D, Jung KH, Mailliez A, Fan Z, Tennevet I, Zhang J, Nagy T, Sonke GS, Sun Q, Parton M, Colleoni MA, Schmidt M, Brufsky AM, Razaq W, Kaufman B, Cameron D, Campbell C, Tutt ANJ; OlympiA Clinical Trial Steering Committee and Investigators. Geyer CE Jr, et al. Among authors: schmidt m. Ann Oncol. 2022 Dec;33(12):1250-1268. doi: 10.1016/j.annonc.2022.09.159. Epub 2022 Oct 10. Ann Oncol. 2022. PMID: 36228963 Free PMC article. Clinical Trial.
Plants with cosmetic uses.
Mansoor K, Aburjai T, Al-Mamoori F, Schmidt M. Mansoor K, et al. Among authors: schmidt m. Phytother Res. 2023 Dec;37(12):5755-5768. doi: 10.1002/ptr.8019. Epub 2023 Sep 28. Phytother Res. 2023. PMID: 37770185 Review.
Animal models of PTSD: a challenge to be met.
Richter-Levin G, Stork O, Schmidt MV. Richter-Levin G, et al. Among authors: schmidt mv. Mol Psychiatry. 2019 Aug;24(8):1135-1156. doi: 10.1038/s41380-018-0272-5. Epub 2018 Oct 19. Mol Psychiatry. 2019. PMID: 30816289 Free PMC article. Review.
Human MCTS1-dependent translation of JAK2 is essential for IFN-γ immunity to mycobacteria.
Bohlen J, Zhou Q, Philippot Q, Ogishi M, Rinchai D, Nieminen T, Seyedpour S, Parvaneh N, Rezaei N, Yazdanpanah N, Momenilandi M, Conil C, Neehus AL, Schmidt C, Arango-Franco CA, Voyer TL, Khan T, Yang R, Puchan J, Erazo L, Roiuk M, Vatovec T, Janda Z, Bagarić I, Materna M, Gervais A, Li H, Rosain J, Peel JN, Seeleuthner Y, Han JE, L'Honneur AS, Moncada-Vélez M, Martin-Fernandez M, Horesh ME, Kochetkov T, Schmidt M, AlShehri MA, Salo E, Saxen H, ElGhazali G, Yatim A, Soudée C, Sallusto F, Ensser A, Marr N, Zhang P, Bogunovic D, Cobat A, Shahrooei M, Béziat V, Abel L, Wang X, Boisson-Dupuis S, Teleman AA, Bustamante J, Zhang Q, Casanova JL. Bohlen J, et al. Among authors: schmidt m. Cell. 2023 Nov 9;186(23):5114-5134.e27. doi: 10.1016/j.cell.2023.09.024. Epub 2023 Oct 23. Cell. 2023. PMID: 37875108 Free PMC article.
Leveraging Large Language Models for Decision Support in Personalized Oncology.
Benary M, Wang XD, Schmidt M, Soll D, Hilfenhaus G, Nassir M, Sigler C, Knödler M, Keller U, Beule D, Keilholz U, Leser U, Rieke DT. Benary M, et al. Among authors: schmidt m. JAMA Netw Open. 2023 Nov 1;6(11):e2343689. doi: 10.1001/jamanetworkopen.2023.43689. JAMA Netw Open. 2023. PMID: 37976064 Free PMC article.
Risk factors for breast cancer subtypes by race and ethnicity: a scoping review.
Hurson AN, Ahearn TU, Koka H, Jenkins BD, Harris AR, Roberts S, Fan S, Franklin J, Butera G, Keeman R, Jung AY, Middha P, Gierach GL, Yang XR, Chang-Claude J, Tamimi RM, Troester MA, Bandera EV, Abubakar M, Schmidt MK, Garcia-Closas M. Hurson AN, et al. Among authors: schmidt mk. J Natl Cancer Inst. 2024 Dec 1;116(12):1992-2002. doi: 10.1093/jnci/djae172. J Natl Cancer Inst. 2024. PMID: 39018167 Free PMC article.
[Therapie pathologischer Narben].
Riedemann HI, Schmidt MF, Baron JM. Riedemann HI, et al. Among authors: schmidt mf. J Dtsch Dermatol Ges. 2023 Jul;21(7):761-777. doi: 10.1111/ddg.15088_g. J Dtsch Dermatol Ges. 2023. PMID: 37427735 German.
Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational study.
Martucci G, Schmidt M, Agerstrand C, Tabatabai A, Tuzzolino F, Giani M, Ramanan R, Grasselli G, Schellongowski P, Riera J, Hssain AA, Duburcq T, Gorjup V, De Pascale G, Buabbas S, Gannon WD, Jeon K, Trethowan B, Fanelli V, Chico JI, Balik M, Broman LM, Pesenti A, Combes A, Ranieri MV, Foti G, Buscher H, Tanaka K, Lorusso R, Arcadipane A, Brodie D; International ECMO Network (ECMONet). Martucci G, et al. Among authors: schmidt m. Lancet Respir Med. 2023 Mar;11(3):245-255. doi: 10.1016/S2213-2600(22)00353-8. Epub 2022 Oct 11. Lancet Respir Med. 2023. PMID: 36240836
10,661 results
You have reached the last available page of results. Please see the User Guide for more information.